skip navigation



NOTES:


Source

(Pub. L. 91–513, title III, § 1003, Oct. 27, 1970, 84 Stat. 1286; Pub. L. 95–633, title I, § 106, Nov. 10, 1978, 92 Stat. 3772; Pub. L. 98–473, title II, § 522, Oct. 12, 1984, 98 Stat. 2076; Pub. L. 109–57, § 1(b), Aug. 2, 2005, 119 Stat. 592.)

References in Text

Schedules I, II, III, IV and V, referred to in text, are set out in section 812 (c) of this title.

Amendments

2005—Subsec. (f). Pub. L. 109–57 added subsec. (f).
1984—Subsec. (e). Pub. L. 98–473 in cl. (1) inserted provisions for consumption for medical, etc., purposes, added cls. (2) and (3), and struck out former cls. (2) to (4), respectively, relating to a special controlled substance invoice, two additional copies of the invoice, and exportation of a nonnarcotic controlled substance in schedule III, IV, or V, also listed in schedule I or II of the Convention.
1978—Subsec. (e)(4). Pub. L. 95–633 added par. (4).

Effective Date of 1978 Amendment

Amendment by Pub. L. 95–633 effective on date the Convention on Psychotropic Substances enters into force in the United States [July 15, 1980], see section 112 of Pub. L. 95–633, set out as an Effective Date note under section 801a of this title.


LII has no control over and does not endorse any external Internet site that contains links to or references LII.
Study law abroad: Cornell Paris Institute